Document Detail

Inhibition of HTRA3 stimulates trophoblast invasion during human placental development.
MedLine Citation:
PMID:  21035848     Owner:  NLM     Status:  In-Process    
Controlled invasion of extravillous trophoblast (EVT) is necessary for implantation and placentation. The serine protease HTRA3 is highly expressed in decidual cells in the late secretory phase of the menstrual cycle and throughout pregnancy. During the first trimester it is expressed in most trophoblast cell types, but not in the invading interstitial trophoblast. HTRA3 and its family members are down-regulated in a number of cancers and are proposed as tumour-suppressors. The current study investigated whether inhibiting HTRA3 in a first trimester trophoblast cell line expressing high levels of HTRA3 would alter invasion. HTR-8/SVneo (HTR-8, derived from first trimester placenta) and a number of choriocarcinoma cells (JEG-3, AC-1M88 and AC-1M32) were screened for HTRA3 expression. Only HTR-8 cells expressed high levels of HTRA3 mRNA, consistent with HTRA3 being down-regulated in cancer. Western blotting and immunofluorescence confirmed HTRA3 protein expression and localisation in HTR-8 cells. HTRA3 was detected in conditioned medium of HTR-8 cells, confirming its secretory nature. For functional studies, both long and short forms of recombinant human HTRA3, wild type and protease-inactive mutant (S(305)A) were produced using wheat-germ cell-free technology. Both have a similar molecular size, but the mutants have negligible protease activity. In addition, the mutants significantly inhibited the wild type protease activity, supporting their dominant-negative inhibition and utility as specific inhibitors of the wild type protein. Inhibition of HTRA3 by exogenous addition of HTRA3 mutant resulted in a significant increase in HTR-8 cell invasion. These results strongly support the hypothesis that HTRA3 is an inhibitor of trophoblast invasion during placental development.
H Singh; S-i Makino; Y Endo; G Nie
Related Documents :
2156618 - Expression of the retrotransposons, intracisternal a-particles, during neoplastic progr...
3069768 - Regional and genotypic differences in stromal-vascular cells from obese and lean zucker...
18239888 - Role of uterine natural killer cells in angiogenesis of human decidua of the first-trim...
2925948 - Suppression of mitogenic response of peripheral blood mononuclear cells by bovine mamma...
20589838 - Continuous scalable blood filtration device using inertial microfluidics.
23200838 - A polysaccharide fraction of adlay seed (coix lachryma-jobi l.) induces apoptosis in hu...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-29
Journal Detail:
Title:  Placenta     Volume:  31     ISSN:  1532-3102     ISO Abbreviation:  Placenta     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006349     Medline TA:  Placenta     Country:  England    
Other Details:
Languages:  eng     Pagination:  1085-92     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Prince Henry's Institute of Medical Research, 246 Clayton Road, Clayton, Victoria 3168, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pathologic basis of echogenic cystic lesions in the human placenta: role of ultrasound-guided wire l...
Next Document:  Chronic intervillositis of the placenta: a systematic review.